The number of patients with excess levels of E2, progesterone and testosterone, or lower levels of FSH and LH was 6%, 0%, 0%, 3% and 14%, respectively in postmenopausal women with type 2 endometrial cancer (n = 16). Here, PLOD1 is linked to endometrial cancer.